Investment AB Oresund (publ) Net debt/EBITDA
What is the Net debt/EBITDA of Investment AB Oresund (publ)?
The Net debt/EBITDA of Investment AB Oresund (publ) is 1.01
What is the definition of Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA of companies in the Miscellaneous sector on LSE compared to Investment AB Oresund (publ)
What does Investment AB Oresund (publ) do?
Investment AB Oresund is a publicly owned investment manager. Investment AB Oresund was founded in 1890 and is based in Stockholm, Sweden.
Companies with net debt/ebitda similar to Investment AB Oresund (publ)
- Imperial Oil has Net debt/EBITDA of 1.00
- Quantum Graphite has Net debt/EBITDA of 1.00
- GOLO Mobile has Net debt/EBITDA of 1.00
- Applied Energetics has Net debt/EBITDA of 1.01
- Supernova Metals has Net debt/EBITDA of 1.01
- Palatin Technologies has Net debt/EBITDA of 1.01
- Investment AB Oresund (publ) has Net debt/EBITDA of 1.01
- Tencent has Net debt/EBITDA of 1.01
- Ryanair Plc has Net debt/EBITDA of 1.01
- NOXXON Pharma NV has Net debt/EBITDA of 1.02
- Appili Therapeutics Inc has Net debt/EBITDA of 1.02
- Whitecap Resources has Net debt/EBITDA of 1.02
- Smith & Wesson Brands has Net debt/EBITDA of 1.02